The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes the importance of distinguishing colonization from infection when interpreting microbiology results. Colonization refers to the presence of microorganisms on or within the body without causing clinical signs or symptoms of disease. In older adults, especially those in healthcare settings, asymptomatic bacteriuria is common and does not meet criteria for a urinary tract infection (UTI).
In this scenario, the presence of Enterococcus faecium in a urine culture in the absence of urinary symptoms- such as dysuria, urgency, fever, or suprapubic pain-indicates colonization rather than infection. The Study Guide notes that treating asymptomatic bacteriuria does not improve patient outcomes and may contribute to antimicrobial resistance, adverse drug events, and unnecessary healthcare costs. Therefore, antibiotics are not indicated.
Option A is incorrect because Enterococcus species are not transmitted via the airborne route; Standard Precautions are sufficient. Option B is incorrect because laboratory findings alone do not define infection without corresponding clinical symptoms. Option D is less accurate because contamination is more likely with mixed flora or improper collection; isolation of a known urinary colonizer in an asymptomatic patient is more consistent with colonization.
Accurate interpretation of such findings supports antimicrobial stewardship principles and aligns with evidence-based infection prevention practices tested on the CIC exam.

The scenario involves a needlestick injury sustained by a phlebotomist during the resuscitation of a patient diagnosed with Neisseria meningitidis infection, characterized by a petechial rash, meningitis, and cardiac arrest. Neisseria meningitidis is a gram-negative diplococcus that can cause meningococcal disease, including meningitis and septicemia, and is transmitted through direct contact with respiratory secretions or, in rare cases, blood exposure. The exposure management for the phlebotomist must align with infection control guidelines, such as those from the Certification Board of Infection Control and Epidemiology (CBIC) and the CDC, to prevent potential infection. Let’s evaluate each option:
* A. Prophylactic rifampin plus isoniazid: Prophylactic antibiotics are recommended for close contacts of individuals with meningococcal disease to prevent secondary cases. Rifampin is a standard prophylactic agent for Neisseria meningitidis exposure, typically administered as a 2-day course (e.g., 600 mg every
12 hours for adults). Isoniazid, however, is used for tuberculosis (TB) prophylaxis and is not indicated for meningococcal disease. Combining rifampin with isoniazid is incorrect, as it reflects a confusion with TB management rather than meningococcal exposure. This option is not appropriate.
* B. A tuberculin skin test now and in ten weeks: A tuberculin skin test (TST) or interferon-gamma release assay (IGRA) is used to screen for latent tuberculosis infection, with a follow-up test at 8-10 weeks to detect conversion after potential TB exposure. Neisseria meningitidis is not related to TB, and a needlestick injury from a meningococcal patient does not warrant TB testing. This option is irrelevant to the scenario and not the correct exposure management.
* C. Work furlough from day ten to day 21 after exposure: Neisseria meningitidis has an incubation period of 2-10 days, with a maximum of about 14 days in rare cases. The CDC and WHO recommend that healthcare workers exposed to meningococcal disease via needlestick or mucosal exposure be monitored for signs of infection (e.g., fever, rash) and, if symptomatic, isolated and treated.
Additionally, a work restriction or furlough from day 10 to day 21 after exposure is advised to cover the potential incubation period, especially if prophylaxis is declined or contraindicated. This allows time to observe for symptoms and prevents transmission to vulnerable patients. This is a standard infection control measure and the most appropriate initial management step pending prophylaxis decision.
* D. A review of the phlebotomist’s hepatitis B vaccine status: Reviewing hepatitis B vaccine status is a critical step following a needlestick injury, as hepatitis B can be transmitted through blood exposure.
However, this applies to bloodborne pathogens (e.g., HBV, HCV, HIV) and is not specific to Neisseria meningitidis, which is primarily a respiratory or mucosal pathogen. While hepatitis B management (e.
g., post-exposure prophylaxis with hepatitis B immunoglobulin or vaccine booster) should be addressed as part of a comprehensive needlestick protocol, it is not the first or most relevant priority for meningococcal exposure.
The best answer is C, as the work furlough from day 10 to day 21 after exposure addresses the specific risk of meningococcal disease following a needlestick injury. This aligns with CBIC’s focus on timely intervention and work restriction to prevent transmission in healthcare settings. Prophylactic antibiotics (e.g., rifampin) should also be considered, but the question asks for the exposure management, and furlough is a primary control measure. Hepatitis B and TBconsiderations are secondary and managed separately.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which includes protocols for managing exposure to communicable diseases like meningococcal infection.
CBIC Examination Content Outline, Domain IV: Environment of Care, which addresses work restrictions and exposure management.
CDC Guidelines for Meningococcal Disease Prevention and Control (2023), which recommend work furlough and monitoring for exposed healthcare workers.

When an infection preventionist (IP) is informed of a measles outbreak in a nearby community, the immediate priority is to protect healthcare workers and patients from potential exposure, particularly in a healthcare setting where vulnerable populations are present. Working with Occupational Health, the IP must follow a structured approach to mitigate the risk of transmission, guided by principles from the Certification Board of Infection Control and Epidemiology (CBIC) and public health guidelines. Let’s evaluate each option to determine the first priority:
* A. Isolate employees who have recently traveled to areas with measles outbreaks: Isolating employees who may have been exposed to measles during travel is an important infection control measure to prevent transmission within the facility. However, this action assumes that exposure has already occurred and requires identification of affected employees first. Without knowing the immunity status of the workforce, this step is reactive rather than preventive and cannot be the first priority.
* B. Reassign employees who are pregnant from caring for patients with suspected measles: Reassigning pregnant employees is a protective measure due to the severe risks measles poses to fetuses (e.g., congenital rubella syndrome risks, though measles itself is more about maternal complications). This action is specific to a subset of employees and depends on identifying patients with suspected measles, which may not yet be confirmed. It is a secondary step that follows assessing overall immunity and exposure risks, making it inappropriate as the first priority.
* C. Verify that employees in high-risk exposure areas of the facility have adequate immunity to measles:
Verifying immunity is the foundational step in preventing measles transmission in a healthcare setting.
Measles is highly contagious, and healthcare workers in high-risk areas (e.g., emergency departments, pediatric wards) are at increased risk of exposure. The CBIC and CDC recommend ensuring that all healthcare personnel have documented evidence of measles immunity (e.g., two doses of MMR vaccine, laboratory evidence of immunity, or prior infection) as a primary infection control strategy during outbreaks. This step allows the IP to identify vulnerable employees, implement targeted interventions, and comply with occupational health regulations. It is the most proactive and immediate priority when an outbreak is reported in the community.
* D. Set up a mandatory vaccination clinic in collaboration with Occupational Health and local public health partners: Establishing a vaccination clinic is a critical long-term strategy to increase immunity and control the outbreak. However, this requires planning, resource allocation, and coordination, which take time. It is a subsequent step that follows verifying immunity status to identify those who need vaccination. While important, it cannot be the first priority due to its logistical demands.
The first priority is C, as verifying immunity among employees in high-risk areas establishes a baseline to prevent transmission before reactive measures (e.g., isolation, reassignment) or broader interventions (e.g., vaccination clinics) are implemented. This aligns with CBIC’s focus on proactive risk assessment and occupational health safety during infectious disease outbreaks, ensuring a rapid response to protect the healthcare workforce and patients.
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which prioritizes immunity verification during outbreaks.
CBIC Examination Content Outline, Domain IV: Environment of Care, which includes ensuring employee immunity as part of outbreak preparedness.
CDC Guidelines for Measles Prevention (2023), which recommend verifying healthcare worker immunity as the initial step during a measles outbreak.

Even if the healthcare worker is negative for bloodborne pathogens, the patienthas the right to be informed of a potential exposure. Transparency builds trust and aligns with ethical obligations in patient care.
* TheAPIC Textstates:
“Providers should inform patients when an HAI or other exposure event occurs, regardless of whether the exposure results in harm or is caused by negligence.” Courts and professional guidelines support disclosure.
* CBIC and OSHA guidelinesemphasize prompt and transparent reporting of exposures.
* OptionsC and Dare incorrect because the lack of infection does not negate the ethical duty to inform the patient.
References:
APIC Text, 4th Edition, Chapter 8 – Legal Issues and Patient Rights

According to CDC and APIC guidelines, a surgical mask is required when performing lumbar punctures to prevent bacterial contamination (e.g., meningitis caused by droplet transmission of oral flora).
Why the Other Options Are Incorrect?
* A. Personal eyeglasses should be worn during suctioning – Incorrect because eyeglasses do not provide adequate eye protection. Goggles or face shields should be used.
* C. Gloves should be worn when handling or touching a cardiac monitor that has been disinfected
– Not necessary unless recontamination is suspected.
* D. Eye protection should be worn when providing patient care after unprotected exposure – Eye protection should be used before exposure, not just after.
CBIC Infection Control Reference
APIC states that surgical masks must be worn for procedures such as lumbar puncture to reduce infection risk.

The correct answer is D, “Study,” as this is the step in the Shewhart/Deming cycle (commonly known as the Plan-Do-Study-Act [PDSA] cycle) where the results of the interventions are compared with the original goal.
According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the PDSA cycle is a systematic approach to quality improvement, widely used in infection control programs to test and refine interventions. The cycle consists of four stages: Plan (designing the intervention and setting goals), Do (implementing the intervention on a small scale), Study (analyzing the data and comparing outcomes against the original goal), and Act (standardizing successful changes or adjusting based on findings) (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 – Evaluate the effectiveness of educational programs). The Study phase is critical for assessing whether the intervention achieved the intended reduction in infection rates or other performance metrics, providing evidence to guide the next steps.
Option A (Do) involves the execution of the planned intervention, focusing on implementation rather than evaluation, so it does not include comparing results. Option B (Act) is the final step where successful interventions are implemented on a broader scale or adjustments are made, but it follows the comparison made in the Study phase. Option C (Plan) is the initial stage of setting objectives and designing the intervention, which occurs before any results are available for comparison.
The emphasis on the Study phase aligns with CBIC’s focus on using data to evaluate the effectiveness of infection prevention strategies, ensuring that performance improvement projects are evidence-based and goal- oriented (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 – Evaluate the effectiveness of infection prevention and control interventions). This step enables the infection preventionist to determine if the original goal-such as reducing healthcare-associated infections-was met, facilitating continuous improvement.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 – Evaluate the effectiveness of infection prevention and control interventions; Domain IV:
Education and Research, Competency 4.2 – Evaluate the effectiveness of educational programs.

* The Chi-square test is the most appropriate test for comparing infection rates (categorical data) before and after an intervention.
CBIC Infection Control References:
* CIC Study Guide, “Statistical Analysis in Infection Control,” Chapter 5.

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies the randomized controlled trial (RCT) as the gold standard study design for assessing the benefit of a new treatment. RCTs are specifically designed to determine causality by minimizing bias and confounding variables through random assignment of participants to intervention and control groups. This ensures that differences in outcomes can be attributed with the highest level of confidence to the treatment being studied rather than to external factors.
In an RCT, participants are randomly allocated to receive either the new treatment or a comparison intervention (such as standard therapy or placebo). Randomization balances known and unknown risk factors between groups, while controlled conditions allow precise measurement of treatment effects. This design is particularly important when evaluating new therapies, medications, or interventions where efficacy and safety must be clearly demonstrated.
The other study designs listed are less rigorous for assessing treatment benefit. An interrupted time series is useful for evaluating system-level interventions over time but is more susceptible to confounding influences.
A correlational study can identify associations but cannot establish cause and effect. A parallel group study without randomization lacks adequate control for bias and confounding.
For CIC exam preparation, it is essential to recognize that when the objective is to assess the benefit or effectiveness of a new treatment, a randomized controlled trial provides the strongest and most reliable evidence, making it the best answer.

An epidemic curve, commonly used in infection prevention and control to visualize the progression of an outbreak, is a graphical representation of the number of cases over time. According to the principles outlined by the Certification Board of Infection Control and Epidemiology (CBIC), an epidemic curve is most effectively displayed using a bar graph or histogram that tracks the number of new cases by date or time interval (e.g., daily, weekly) without revealing patient identifiers, ensuring compliance with privacy regulations such as HIPAA. Option C aligns with this standard practice, as it specifies preparing a bar graph with no patient identifiers, focusing solely on the number of cases over a specific period. This allows infection preventionists to identify patterns, such as the peak of the outbreak or potential sources of transmission, while maintaining confidentiality.
Option A is incorrect because listing case names and room numbers with a logarithmic scale violates patient privacy and is not a standard method for constructing an epidemic curve. Logarithmic scales are typically used for data with a wide range of values, but they are not the preferred format for epidemic curves, which prioritize clarity over time. Option B is also incorrect, as using medical record numbers and scatter plots to show days in the facility to onset does not align with the definition of an epidemic curve, which focuses on case counts over time rather than individual patient timelines or scatter plot formats. Option D is inappropriate because a scatter plot by patient location emphasizes spatial distribution rather than the temporal progression central to an epidemic curve. While location data can be useful in outbreak investigations, it is typically analyzed separately from the epidemic curve.
The CBIC emphasizes the importance of epidemic curves in the “Identification of Infectious Disease Processes” domain, where infection preventionists use such tools to monitor and control outbreaks (CBIC Practice Analysis, 2022). Specifically, the use of anonymized data in graphical formats is a best practice to protect patient information while providing actionable insights, as detailed in the CBIC Infection Prevention and Control (IPC) guidelines.
References:
* CBIC Practice Analysis, 2022.
* CBIC Infection Prevention and Control Guidelines (IPC), Section on Outbreak Investigation and Epidemic Curve Construction.

The correct answer is A, “Durability,” as it is a critical factor to consider when evaluating countertop surface materials. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the selection of materials in healthcare settings, including countertop surfaces, must prioritize infection prevention and control. Durability ensures that the surface can withstand frequent cleaning, disinfection, and physical wear without degrading, which is essential to maintain a hygienic environment and prevent the harboring of pathogens (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 – Implement environmental cleaning and disinfection protocols). Durable materials, such as solid surface composites or stainless steel, resist scratches, cracks, and moisture damage, reducing the risk of microbial growth and cross-contamination, which are significant concerns in healthcare facilities.
Option B (sink design) relates more to the plumbing and fixture layout rather than the inherent properties of the countertop material itself. While sink placement and design are important for workflow and hygiene, they are secondary to the material’s characteristics. Option C (accessibility) is a consideration for user convenience and compliance with the Americans with Disabilities Act (ADA), but it pertains more to the installation and layout rather than the material’s suitability for infection control. Option D (faucet placement) affects usability and water management but is not a direct attribute of the countertop material.
The emphasis on durability aligns with CBIC’s focus on creating environments that support effective cleaning and disinfection practices, which are vital for preventing healthcare-associated infections (HAIs). Selecting durable materials helps ensure long-term infection prevention efficacy, making it a primary factor in the evaluation process (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 – Evaluate the environment for infection risks).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.4 – Implement environmental cleaning and disinfection protocols, 3.5 – Evaluate the environment for infection risks.

The proper use of chemical disinfectants is a critical aspect of infection control, as outlined by the Certification Board of Infection Control and Epidemiology (CBIC). Chemical disinfectants are used to eliminate or reduce pathogenic microorganisms on inanimate objects, and their effective application requires adherence to specific protocols to ensure safety and efficacy. Let’s evaluate each option based on infection control standards:
* A. All items to be processed must be cleaned prior to being submerged in solution.: This statement is a fundamental principle of disinfectant use. Cleaning (e.g., removing organic material such as blood, tissue, or dirt) is a prerequisite before disinfection because organic matter can inactivate or reduce the effectiveness of chemical disinfectants. The CBIC emphasizes that proper cleaning is the first step in the disinfection process to ensure that disinfectants can reach and kill microorganisms. This step is universally required for all levels of disinfection (low, intermediate, and high), making it a characterizing feature of proper use.
* B. The label on the solution being used must indicate that it kills all viable micro-organisms.: This statement is misleading. No disinfectant can be guaranteed to kill 100% of all viable microorganisms under all conditions, as efficacy depends on factors like contact time, concentration, and the presence of organic material. Disinfectant labels typically indicate the types of microorganisms (e.g., bacteria, viruses, fungi) and the level of disinfection (e.g., high-level, intermediate-level) they are effective against, based on standardized tests (e.g., EPA or FDA guidelines). Claiming that a solution kills all viable microorganisms is unrealistic and not a requirement for proper use; instead, the label must specify the intended use and efficacy, which varies by product.
* C. The solution should be adaptable for use as an antiseptic.: An antiseptic is a chemical agent used on living tissue (e.g., skin) to reduce microbial load, whereas a disinfectant is used on inanimate surfaces.
While some chemicals (e.g., alcohol) can serve both purposes, this is not a requirement for proper disinfectant use. The adaptability of a solution for antiseptic use is irrelevant to its classification or application as a disinfectant, which focuses on environmental or equipment decontamination. This statement does not characterize proper disinfectant use.
* D. A chemical indicator must be used with items undergoing high-level disinfection.: Chemical indicators (e.g., test strips or tapes) are used to verify that the disinfection process has met certain parameters (e.g., concentration or exposure time), particularly in sterilization or high-level disinfection (HLD). While this is a recommended practice for quality assurance in HLD (e.g., with glutaraldehyde or hydrogen peroxide), it is not a universal requirement for all chemical disinfectant use. HLD applies specifically to semi-critical items (e.g., endoscopes), and the need for indicators depends on the protocol and facility standards. This statement is too narrow and specific to characterize the proper use of chemical disinfectants broadly.
The correct answer is A, as cleaning prior to disinfection is a foundational and universally applicable step in the proper use of chemical disinfectants. This aligns with CBIC guidelines, which stress the importance of a clean surface to maximize disinfectant efficacy and prevent infection transmission in healthcare settings.
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain IV:
Environment of Care, which mandates cleaning as a prerequisite for effective disinfection.
CBIC Examination Content Outline, Domain III: Prevention and Control of Infectious Diseases, which includes protocols for the proper use of disinfectants, emphasizing pre-cleaning.
CDC Guidelines for Disinfection and Sterilization in Healthcare Facilities (2021), which reinforce that cleaning must precede disinfection to ensure efficacy.

Meningococcal infections, such as Neisseria meningitidis, are transmitted via respiratory droplets. According to APIC and CDC guidelines, patients with meningococcal disease should be placed on Droplet Precautions upon admission. These precautions can be discontinued after 24 hours of effective antibiotic therapy.
Why the Other Options Are Incorrect?
* B. Droplet precautions must continue – Droplet Precautions are not needed beyond 24 hours of appropriate therapy because treatment rapidly reduces infectiousness.
* C. Airborne precautions may be discontinued after 24 hours of therapy – Meningococcal infection is not airborne, so Airborne Precautions are never required.
* D. Airborne precautions must continue – Incorrect because meningococci do not transmit via airborne particles.
CBIC Infection Control Reference
According to APIC guidelines, Droplet Precautions should be maintained for at least 24 hours after effective antibiotic therapy initiation.

To determine the number of employees who seroconverted (became infected) after a needlestick exposure, we use the given data:
* Total Needlestick Injuries: 250
* Needlestick Injuries Involving Bloodborne Pathogens: 100
* Seroconversion Rate: 2%
Calculation:

Why Other Options Are Incorrect:
* A. 1: Incorrect calculation; 2% of 100 is 2, not 1.
* C. 5: Overestimates the actual number of infections.
* D. 10: Exceeds the calculated value based on given data.
CBIC Infection Control References:
* APIC Text, “Occupational Exposure and Seroconversion Risks”.
* APIC Text, “Bloodborne Pathogens and Needlestick Injury Prevention”

The correct answer is D, “Peracetic acid,” as this agent is appropriate for the disinfection of bronchoscopes.
According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, bronchoscopes are semi-critical devices that require high-level disinfection (HLD) to eliminate all microorganisms except high levels of bacterial spores, as they come into contact with mucous membranes but not sterile tissues. Peracetic acid is recognized by the Centers for Disease Control and Prevention (CDC) and the Association for the Advancement of Medical Instrumentation (AAMI) as an effective high-level disinfectant for endoscopes, including bronchoscopes, due to its broad-spectrum antimicrobial activity, rapid action, and compatibility with the delicate materials (e.g., optics and channels) of these devices (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 – Ensure safe reprocessing of medical equipment). It is commonly used in automated endoscope reprocessors, ensuring thorough disinfection when combined with proper cleaning and rinsing protocols.
Option A (iodophor) is typically used for intermediate-level disinfection and skin antisepsis, but it is not sufficient for high-level disinfection of bronchoscopes unless specifically formulated and validated for this purpose, which is uncommon. Option B (alcohol) is effective against some pathogens but evaporates quickly, fails to penetrate organic material, and is not recommended for HLD of endoscopes due to potential damage to internal components and inadequate sporicidal activity. Option C (phenolic) is suitable for surface disinfection but lacks the efficacy required for high-level disinfection of semi-critical devices like bronchoscopes, as it does not reliably eliminate all microbial threats, including mycobacteria.
The selection of peracetic acid aligns with CBIC’s emphasis on evidence-based reprocessing practices to prevent healthcare-associated infections (HAIs) associated with endoscope use (CBIC Practice Analysis,
2022, Domain III: Infection Prevention and Control, Competency 3.4 – Implement environmental cleaning and disinfection protocols). This choice ensures patient safety by adhering to manufacturer and regulatory guidelines, such as those in AAMI ST91 (AAMI ST91:2015, Flexible and semi-rigid endoscope processing in health care facilities).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 – Ensure safe reprocessing of medical equipment, 3.4 – Implement environmental cleaning and disinfection protocols. AAMI ST91:2015, Flexible and semi-rigid endoscope processing in health care facilities. CDC Guidelines for Disinfection and Sterilization in Healthcare Facilities, 2019.

The correct answer is B, “Competence,” as it defines the essential knowledge, behaviors, and skills that an individual should possess and demonstrate to practice in a specific discipline. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, competence encompasses the integrated application of knowledge, skills, and behaviors required to perform effectively in a professional role, such as infection prevention and control. Competence goes beyond mere knowledge or training by including the ability to apply these attributes in real-world scenarios, ensuring safe and effective practice (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.3 – Assess competence of healthcare personnel). This holistic definition is critical in healthcare settings, where demonstrated competence-through actions like proper hand hygiene or outbreak management-directly impacts patient safety and infection prevention outcomes.
Option A (certification) refers to a formal recognition or credential (e.g., CIC certification) that validates an individual’s qualifications, but it is an outcome or process rather than the definition of the underlying abilities.
Option C (knowledge) represents the theoretical understanding or factual basis of a discipline, which is a component of competence but not the full scope that includes behaviors and skills. Option D (training) involves the education or instruction provided to develop skills and knowledge, serving as a means to achieve competence rather than defining it.
The focus on competence aligns with CBIC’s emphasis on ensuring that healthcare personnel are equipped to meet the demands of infection prevention through a combination of education, practice, and evaluation (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 – Evaluate the effectiveness of educational programs). This definition supports the development of professionals who can adapt and perform effectively in dynamic healthcare environments.
References: CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competencies 4.2 – Evaluate the effectiveness of educational programs, 4.3 – Assess competence of healthcare personnel.

The correct answer is C, “the device manufacturer’s written instructions for use,” as this is the factor that determines the appropriate cleaning and disinfection process for a particular surgical instrument. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the reprocessing of surgical instruments must follow the specific instructions provided by the device manufacturer to ensure safety and efficacy. These instructions account for the instrument’s material, design, and intended use, specifying the appropriate cleaning agents, disinfection methods, sterilization techniques, and contact times to prevent damage and ensure the elimination of pathogens (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 – Ensure safe reprocessing of medical equipment). This is also mandated by regulatory standards, such as those from the Food and Drug Administration (FDA) and the Association for the Advancement of Medical Instrumentation (AAMI), which require adherence to manufacturer guidelines to maintain device integrity and patient safety.
Option A (all surgical instruments are cleaned and sterilized in the same manner) is incorrect because different instruments have unique characteristics (e.g., materials like stainless steel vs. delicate optics), necessitating tailored reprocessing methods rather than a one-size-fits-all approach. Option B (instruments contaminated with blood must be bleach cleaned first) is a misconception; while blood contamination requires thorough cleaning, bleach is not universally appropriate and may damage certain instruments unless specified by the manufacturer. Option D (the policies of the sterile processing department) may guide internal procedures but must be based on and subordinate to the manufacturer’s instructions to ensure compliance and effectiveness.
The emphasis on manufacturer instructions aligns with CBIC’s focus on evidence-based reprocessing practices to prevent healthcare-associated infections (HAIs) and protect patients (CBIC Practice Analysis,
2022, Domain III: Infection Prevention and Control, Competency 3.5 – Evaluate the environment for infection risks). Deviating from these guidelines can lead to inadequate sterilization or instrument damage, increasing infection risks.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 – Ensure safe reprocessing of medical equipment, 3.5 – Evaluate the environment for infection risks. AAMI ST79:2017, Comprehensive guide to steam sterilization and sterility assurance in health care facilities.

The Certification Study Guide (6th edition) identifies environmental dispersal of microorganisms as the primary reason healthcare construction and renovation activities increase the risk of healthcare-associated infections (HAIs). Construction activities such as demolition, drilling, and ceiling penetration disturb dust and building materials that may harbor fungal spores and other microorganisms, particularly Aspergillus species.
Once aerosolized, these organisms can spread through airflow to patient care areas if containment and ventilation controls are inadequate.
The study guide emphasizes that immunocompromised patients-such as those in oncology units, transplant units, and intensive care settings-are especially vulnerable to infections caused by airborne fungi released during construction. Numerous outbreaks of invasive aspergillosis have been linked directly to renovation and construction projects that lacked appropriate infection control risk assessment (ICRA) measures.
The incorrect options describe secondary or contributory issues but are not the primary mechanism of infection risk. While increased personnel traffic, hand hygiene training, and waste handling are important considerations, they do not represent the central hazard posed by construction. The fundamental risk is airborne dissemination of microorganisms from disrupted environmental reservoirs.
CIC exam questions frequently test knowledge of construction-related infection risks and the importance of engineering controls such as negative pressure containment, HEPA filtration, and dust barriers. Recognizing environmental dispersal as the primary risk underscores why rigorous planning and infection control oversight are essential during renovation projects.
Reference: Certification Study Guide (CBIC/CIC Exam Study Guide), 6th edition, Chapter 9: Environment of Care.

Therapeutic antimicrobial agentsshould ideally bepathogen-directedto minimizeresistance, side effects, and treatment failure. Once thecausative pathogen and its antimicrobial susceptibilities are known, the mostnarrow-spectrum, effectiveagent should be used.
Why the Other Options Are Incorrect?
* A. The infecting agent is unknown- Empiric therapy may be necessary initially, but definitive therapy should be based on pathogen identification.
* B. The patient’s illness warrants treatment prior to culture results- This applies toempiric therapy
, but not todefinitive antimicrobial selection.
* C. The patient’s symptoms suggest likely pathogens- Clinical presentation guidesempiric treatment
, butdefinitive therapy should follow culture and susceptibility testing.
CBIC Infection Control Reference
APIC emphasizes theimportance of selecting antimicrobials based on pathogen identification and susceptibility testingto preventantimicrobial resistance.